
In the phase 2 EVITA trial, vitamin C did not slow clonal growth but was linked to fewer serious adverse events and longer exploratory survival.
Colleen M. O'Leary, RN, MSN, AOCNS, from The James Cancer Hospital, The Ohio State University, discusses the importance of navigation for patients with head and neck cancer.
Colleen M. O'Leary, RN, MSN, AOCNS, clinical nurse specialist, head & neck cancers, coordinator, nursing evidence-based practice, The James Cancer Hospital, The Ohio State University, discusses the importance of navigation for patients with head and neck cancer.






